Written by James T.
Published April 21, 2026

Platelet-rich plasma (PRP) therapy is an emerging, evidence-supported procedure for androgenetic alopecia in men — but results vary significantly by patient selection, protocol, and disease stage.
Platelet-rich plasma (PRP) is a concentration of your own blood's platelets — the small cell fragments that carry growth factors critical to tissue repair. To prepare it, a clinician draws a small blood sample, spins it in a centrifuge to separate the platelet-rich layer, and injects that layer directly into the scalp at the level of the hair follicle.
The working hypothesis is straightforward: growth factors such as platelet-derived growth factor (PDGF), vascular endothelial growth factor (VEGF), and insulin-like growth factor-1 (IGF-1) stimulate follicular cells, prolong the anagen (active growth) phase, and increase blood supply to miniaturizing follicles. The result, in responding patients, is reduced shedding and modest density improvement. It does not create new follicles where none exist; it works on follicles that are weakened but still present.
Because PRP is derived from your own blood, it carries no risk of allergic reaction to a foreign substance. Serious adverse events in published literature are rare.
PRP research has expanded considerably over the past decade, though the field still lacks the large-scale randomized controlled trials (RCTs) that define the standard for FDA-approved drugs.
Key trials and systematic reviews to know:

Bottom line on evidence: PRP shows real biological plausibility and statistically significant results in multiple trials. It is not, however, a first-line monotherapy with the evidence depth of finasteride or minoxidil, both of which carry decades of phase III trial data and FDA approval for androgenetic alopecia.
Because PRP is considered an elective cosmetic procedure, it is not covered by most insurance plans. Based on published price surveys and clinic data:
No standardized pricing exists. Costs vary widely, and higher price does not always correlate with better outcomes. Ask any provider for their specific centrifugation protocol and platelet concentration targets — these are the variables most likely to affect outcome.
Likely candidates: - Men with early-to-moderate androgenetic alopecia (Norwood grades II–IV) - Men who have not responded fully to oral or topical medications alone - Men seeking an adjunct to pharmacologic therapy - Men without active scalp infection or active anticoagulant therapy
Poor or non-candidates: - Men with advanced hair loss (Norwood grade VI–VII) — insufficient viable follicles remain - Men on anticoagulant medications (e.g., warfarin, direct oral anticoagulants) without medical clearance - Men with platelet dysfunction syndromes, active scalp infections, or a current diagnosis of cancer or blood disorders - Men with unrealistic expectations of full regrowth from a procedure alone
The prescribing or treating provider conducts a full scalp and medical assessment before recommending PRP.
Timeline: Most patients do not see meaningful change before 3–6 months of treatment. The scalp must cycle through telogen (resting) and re-enter anagen. Patience is required.
Common side effects: Temporary scalp tenderness, mild swelling, and pinpoint bleeding at injection sites are expected and typically resolve within 24–48 hours. Some patients note a brief increase in shedding early in treatment — this is usually a normal cycling response, not treatment failure.
Call your provider if you experience: Prolonged swelling beyond 72 hours, signs of infection (warmth, pus, spreading redness), or significant pain not resolved with over-the-counter analgesics.

Combination approaches: PRP is frequently combined with pharmacologic agents. Finasteride, an oral 5-alpha reductase inhibitor that blocks conversion of testosterone to dihydrotestosterone (DHT), has robust long-term evidence for slowing pattern hair loss. A compounded topical finasteride + minoxidil formulation — prepared by state-licensed compounding pharmacies in accordance with FDA regulations — allows dual-mechanism treatment applied directly to the scalp. Whether any combination is appropriate for you is a clinical determination made after a full medical intake.
April is Testicular Cancer Awareness Month. As men proactively address hair health, it is worth taking 60 seconds to perform a testicular self-examination (TSE). Testicular cancer is the most common solid malignancy in men aged 15–35, but incidence extends through the fifth decade. The American Cancer Society recommends monthly self-checks: after a warm shower, gently roll each testicle between thumb and fingers, noting any firm lumps, changes in size, or heaviness. Early-stage detection carries a five-year survival rate above 95%, according to NIH National Cancer Institute data. Responsible stewardship of your health means attending to all of it — not just what's visible in the mirror.
Good Guy Rx is a technology platform that connects men to independent licensed physicians and independent state-licensed pharmacies. If you are considering a pharmacologic approach to hair loss — alone or as a complement to a procedure like PRP — the prescribing provider determines whether a medication is appropriate after a structured medical intake. Begin with a hair-loss assessment at care.goodguyrx.com to connect with a licensed provider who can review your history, scalp presentation, and goals.
This article is educational. A licensed provider determines whether you are a candidate after a medical intake.
References
Share this article

Complete your free online visit and see if GLP-1 treatment is right for you.
Get Started